G595-0866 Screening compound: N~3~-(2-morpholinoethyl)-4-oxo-7,8,9,10-tetrahydro-4H,6H-cyclohepta[4,5][1,3]thiazolo[3,2-a]pyrimidine-3-carboxamide

G595-0866 Screening compound: N~3~-(2-morpholinoethyl)-4-oxo-7,8,9,10-tetrahydro-4H,6H-cyclohepta[4,5][1,3]thiazolo[3,2-a]pyrimidine-3-carboxamide
G595-0866 Screening compound: N~3~-(2-morpholinoethyl)-4-oxo-7,8,9,10-tetrahydro-4H,6H-cyclohepta[4,5][1,3]thiazolo[3,2-a]pyrimidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G595-0866
N~3~-(2-morpholinoethyl)-4-oxo-7,8,9,10-tetrahydro-4H,6H-cyclohepta[4,5][1,3]thiazolo[3,2-a]pyrimidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G595-0866

Molecular Formula

C18H24N4O3S (C18 H24 N4 O3 S)

Compound Name

N~3~-(2-morpholinoethyl)-4-oxo-7,8,9,10-tetrahydro-4H,6H-cyclohepta[4,5][1,3]thiazolo[3,2-a]pyrimidine-3-carboxamide

IUPAC name

N-[2-(morpholin-4-yl)ethyl]-3-oxo-8-thia-26-diazatricyclo[7.5.0.0^{27}]tetradeca-1(9)46-triene-4-carboxamide

SMILES

O=C(C1=CN=C2SC(CCCCC3)=C3N2C1=O)NCCN1CCOCC1

InChI

InChI=1S/C18H24N4O3S/c23-16(19-6-7-21-8-10-25-11-9-21)13-12-20-18-22(17(13)24)14-4-2-1-3-5-15(14)26-18/h12H,1-11H2,(H,19,23)

InChI Key

OTDKQNHTPIAENL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27145324

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

376.48

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

0.450

Distribution Coefficient, logD

0.330

Water Solubility, LogSw

-1.60

Polar Surface Area

62.100

Acid Dissociation Constant (pKa)

9.16

Base Dissociation Constant (pKb)

6.87

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

61.10

G595-0866 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

GPCR Targeted Library (31838 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G595-0866 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G595-0866?
Check Price and Availability of G595-0866, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G595-0866 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G595-0866
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G595-0866
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G595-0866 available by request